Lv6
2590 积分 2024-12-14 加入
Pharmacological Targeting of IRF4 As a Therapeutic Strategy for Multiple Myeloma
1个月前
已完结
The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1
1个月前
已完结
The Epigenetic Hallmarks of Cancer
2个月前
已完结
CD22-targeted CD28 bispecific antibody enhances antitumor efficacy of odronextamab in refractory diffuse large B cell lymphoma models
2个月前
已完结
Untangling the ErbB signalling network
2个月前
已完结
Fulzerasib plus cetuximab in first-line KRAS-mutated non-small-cell lung cancer (KROCUS): a single-arm, multicentre, phase 1b/2 trial
3个月前
已完结
Anti-epidermal growth factor receptor monoclonal antibody cetuximab inhibits EGFR/HER-2 heterodimerization and activation
3个月前
已完结
Combined Modality Therapy of A431 Human Epidermoid Cancer Using Anti-EGFr Antibody C225 and Radiation
3个月前
已完结
The resurgence of covalent drugs
3个月前
已完结
Population pharmacokinetics of HM781-36 (poziotinib), pan-human EGF receptor (HER) inhibitor, and its two metabolites in patients with advanced solid malignancies
3个月前
已完结
皖公网安备34019202002308
